Virtual worlds could help men with HIV fight heart disease

NCT ID NCT05242952

Completed Disease control Sponsor: Yale University Source: ClinicalTrials.gov ↗

First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time

Summary

This study tests whether a virtual environment (VE) can help minority men who have sex with men and are living with HIV adopt healthier behaviors to prevent cardiovascular disease. Participants use a computer-based virtual world to access educational quests and other features. The study measures how feasible and acceptable this approach is, and whether it leads to changes in health indicators like body mass index.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: a virtual environment (VE) gaming intervention
What this could lead to: If successful, this approach could offer a new, engaging way to help people with HIV reduce their risk of heart disease and other related health problems.
What could go wrong: This is a small, early-stage study focused on feasibility and acceptability, so it may not show clear health benefits. The virtual environment may not be effective or engaging for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiovascular disorder Coitus HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIOVASCULAR DISEASES

Contacts and locations

Show contact details

Locations

Yale University

Orange, Connecticut, 06477, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.